Group Health Research Institute fast facts
Group Health Research Institute (GHRI) does practical research to keep people healthy.
GHRI is the research arm of Group Health Cooperative, a Seattle-based, consumer-governed, nonprofit health care system that coordinates health care and coverage for more than 600,000 people.
History: Since 1983, the Institute has conducted nonproprietary public-interest research on preventing, diagnosing, and treating major health problems.
Faculty and staff: About 60 health scientists—including physicians, epidemiologists, biostatisticians, psychologists, economists, and health services researchers. Most faculty members have a joint appointment at the University of Washington. GHRI also employs about 300 other staff members.
Funding: In 2013, GHRI’s external revenue exceeded $47 million.
- Federal agencies (NIH, CDC, AHRQ, etc.) = 77% of GHRI's annual budget.
- Grants and contracts from foundations and industry (Robert Wood Johnson, Amgen, Johnson & Johnson, Pfizer, GlaxoSmithKline, etc.) = 13%.
- Group Health = 5%.
- Other (includes industry) = 5%.
Networks: GHRI belongs to several national consortia, including the HMO Research Network, which has data on about 12 million lives. Others include the Cancer Research Network, and the Breast Cancer Surveillance Consortium. GHRI also hosts one of eight federally funded Vaccine and Treatment Evaluation Units.
Productivity: In 2013, GHRI managed a total of 292 active grants and published 353 articles in peer-reviewed medical journals.